TranS1 Inc. (Nasdaq: TSON) is set to buy Baxano Inc., a developer of minimally-invasive spinal devices, for about $23.6 million.

The deal, announced late March 4, includes $550,000 in cash, plus refinancing roughly $3 million of Baxano debt.

Subscribe Now

Complete access to real-time information and analysis of news and trends in the industry.

14-Day Free Trial

No credit card required. Complete access to articles, breaking news and industry data.